Form Type: 4

SEC EDGAR Link
Accession Number:0001209191-14-054896
Date:2014-08-26
Issuer: AVANIR PHARMACEUTICALS, INC. (AVNR)
Original Submission Date:

Reporting Person:

OCAMPO CHRISTINE
20 ENTERPRISE, SUITE 200
ALISO VIEJO, CA 92656

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2014-08-26 S 2,110 d $6.10 79,871 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
Footnotes
IDfootnote
f1 the sales reported on this from 4 were effected pursuant to a trading plan adopted pursuant to rule 10b5-1 under the securities exchange act of 1934, as amended.
f2 includes previously reported shares of common stock underlying restricted stock units granted to the reporting person, which are subject to certain vesting conditions.
WhaleWisdom Logo

Elevate your investments